InvestorsHub Logo
icon url

abew4me

04/13/23 2:53 PM

#410822 RE: Investor2014 #410821

If the LPLV is April 30th, I think they have a good chance of getting the TLR finished by the SH meeting on May 23rd.

*********************************************************************

ANAVEX2-73-RS-003 is a Phase 2/3, Double-blind, Randomized, Placebo-controlled Safety and Efficacy Study in Pediatric Patients With RTT
Actual Study Start Date : July 1, 2020
Estimated Primary Completion Date : April 30, 2023 Last Participant Last Visit
Estimated Study Completion Date : June 1, 2023

https://clinicaltrials.gov/ct2/show/NCT04304482